Overexpression of X-linked inhibitor of apoptosis protein (XIAP), a potent caspase inhibitor, in breast cancer induced resistance to cetuximab-mediated ADCC in both a caspase-dependent and -independent manner (via accumulation of reactive oxygen species) (89). The gene discussed is XIAP; the disease is breast carcinoma.